Skip to main content

Vladimír Dzavík, MD, FRCPC, FSCAI

Case Report
08/01/2008
In the performance of increasingly complex percutaneous coronary interventions (PCIs), there remains an ever-present risk of device fracture or dislodgement. Such occurrences are fortunately infrequent,1 however, they may pose an unfamiliar...
In the performance of increasingly complex percutaneous coronary interventions (PCIs), there remains an ever-present risk of device fracture or dislodgement. Such occurrences are fortunately infrequent,1 however, they may pose an unfamiliar...
In the performance of...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
The Cutting Balloon® (CB) (Interventional Technologies, Letterkerry, Ireland) employs three to four longitudinally mounted microblades that produce clean incisions into plaque or neointima, enhancing lesion dilatation.1 Its use has been...
The Cutting Balloon® (CB) (Interventional Technologies, Letterkerry, Ireland) employs three to four longitudinally mounted microblades that produce clean incisions into plaque or neointima, enhancing lesion dilatation.1 Its use has been...
The Cutting Balloon® (CB)...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
03/10/2009
From the Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Canada. The authors report no conflicts of interest regarding the content herein. Dr. Džavík was supported in part by the Brompton Funds...
From the Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Canada. The authors report no conflicts of interest regarding the content herein. Dr. Džavík was supported in part by the Brompton Funds...
From the Peter Munk Cardiac...
03/10/2009
Journal of Invasive Cardiology
10/29/2019
The presence of intermediate “non-obstructive” saphenous vein graft lesions is a strong predictor of cardiac events. Our study aims to assess the efficacy of sealing these saphenous vein graft lesions with drug-eluting stent implantation for...
The presence of intermediate “non-obstructive” saphenous vein graft lesions is a strong predictor of cardiac events. Our study aims to assess the efficacy of sealing these saphenous vein graft lesions with drug-eluting stent implantation for...
The presence of intermediate...
10/29/2019
Journal of Invasive Cardiology
Original Contribution
09/15/2017
Despite widespread use, evidence to support preemptive IABP insertion for patients undergoing high-risk CABG surgery remains sparse, and in need of a well-defined clinical trial. To inform the design of a prospective trial, we sought to...
Despite widespread use, evidence to support preemptive IABP insertion for patients undergoing high-risk CABG surgery remains sparse, and in need of a well-defined clinical trial. To inform the design of a prospective trial, we sought to...
Despite widespread use, evidence...
09/15/2017
Journal of Invasive Cardiology